Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

Add To Watchlist

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > ONCYs Offering to continue advancement of clinical progams

View:

Post by Noteable on Aug 12, 2023 9:17am

ONCYs Offering to continue advancement of clinical progams

The Company intends to use the proceeds from the Offering to continue the advancement of its pelareorep clinical programs in metastatic breast and pancreatic cancers.

https://www.oncolyticsbiotech.com/press-releases/detail/606/oncolytics-biotech-successfully-raises-us15-million-to

241

Comment

Comment by Noteable on Aug 12, 2023 9:39am

ONCY's official statement is that the proceeds from the Offering are to be used in the continued advancement of its pelareorep clinical programs in metastatic breast and pancreatic cancers https://www.oncolyticsbiotech.com/press-releases/detail/606/oncolytics-biotech-successfully-raises-us15-million-to

164

Comment

Oncolytics Biotech Inc